https://www.selleckchem.com/pr....oducts/ll37-human.ht
lly on this population in this challenging setting. The successful implementation of SBCM demonstrates its adaptability to the ED and may serve as a potential model for EDs seeking to adopt an intervention that overcomes the barrier between the ED encounter and more intensive treatment. ClinicalTrials.gov NCT02586896 . Registered on 27 October 2015. ClinicalTrials.gov NCT02586896 . Registered on 27 October 2015. Spondylolysis is the main cause of low back pain (LBP) in young athletes. There are few studies analyzing the difference of